Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-positive Advanced Breast Cancer
Interventions: DRUG: Pyrotinib Maleate|DRUG: Vinorelbine
Sponsor: Tianjin Medical University Cancer Institute and Hospital